253 related articles for article (PubMed ID: 31912675)
21. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
22. PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component.
Tanigawa M; Naito Y; Akiba J; Kawahara A; Okabe Y; Ishida Y; Ishikawa H; Hisaka T; Fujita F; Yasunaga M; Shigaki T; Sudo T; Mihara Y; Nakayama M; Kondo R; Kusano H; Shimamatsu K; Okuda K; Akagi Y; Yano H
Pathol Res Pract; 2018 Dec; 214(12):2069-2074. PubMed ID: 30477643
[TBL] [Abstract][Full Text] [Related]
23. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.
Rotman M; Sedlis A; Piedmonte MR; Bundy B; Lentz SS; Muderspach LI; Zaino RJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):169-76. PubMed ID: 16427212
[TBL] [Abstract][Full Text] [Related]
24. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
26. Programmed Death Ligand-1 (PD-L1) Expression in Cervical Squamous Cell Carcinoma: Does it Correlate With Outcomes?
Monsrud AL; Avadhani V; Mosunjac MB; Flowers L; Krishnamurti U
Int J Gynecol Pathol; 2023 Nov; 42(6):535-543. PubMed ID: 37562018
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile.
Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Kesting M; Ries J
Cancer Med; 2019 Mar; 8(3):1124-1134. PubMed ID: 30659749
[TBL] [Abstract][Full Text] [Related]
28. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Treatment Response With Proteins Related to Tumor Immunity in Postoperative Irradiated Cervical Cancer Patients.
Mafune S; Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Okuda R; Iwasaki M; Matsuura M; Kubo T; Hirohashi Y; Torigoe T; Saito T; Sakata KI
Anticancer Res; 2024 Jul; 44(7):3077-3086. PubMed ID: 38925822
[TBL] [Abstract][Full Text] [Related]
30. High PD-L1 expression in the tumour cells did not correlate with poor prognosis of patients suffering for oral squamous cells carcinoma: A meta-analysis of the literature.
Troiano G; Caponio VCA; Zhurakivska K; Arena C; Pannone G; Mascitti M; Santarelli A; Lo Muzio L
Cell Prolif; 2019 Mar; 52(2):e12537. PubMed ID: 30443950
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of PD-L1 expression in correlation with neutrophil-to-lymphocyte ratio in squamous cell carcinoma of the lung.
Tashima Y; Kuwata T; Yoneda K; Hirai A; Mori M; Kanayama M; Imanishi N; Kuroda K; Ichiki Y; Tanaka F
Sci Rep; 2020 Jan; 10(1):1243. PubMed ID: 31988315
[TBL] [Abstract][Full Text] [Related]
32. NME4 modulates PD-L1 expression via the STAT3 signaling pathway in squamous cell carcinoma.
Zheng S; Liu Q; Liu T; Yang L; Zhang Q; Shen T; Zhang X; Han X; Lu X
Biochem Biophys Res Commun; 2020 May; 526(1):29-34. PubMed ID: 32192776
[TBL] [Abstract][Full Text] [Related]
33. Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma.
Kim R; Keam B; Kwon D; Ock CY; Kim M; Kim TM; Kim HJ; Jeon YK; Park IK; Kang CH; Kim DW; Kim YT; Heo DS
World J Gastroenterol; 2016 Oct; 22(37):8389-8397. PubMed ID: 27729745
[TBL] [Abstract][Full Text] [Related]
34. The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma.
Takada K; Okamoto T; Toyokawa G; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Oda Y; Maehara Y
Lung Cancer; 2017 Feb; 104():7-15. PubMed ID: 28213003
[TBL] [Abstract][Full Text] [Related]
35. Treatment outcomes of patients with adenocarcinoma of the uterine cervix after definitive radiotherapy and the prognostic impact of tumor-infiltrating CD8+ lymphocytes in pre-treatment biopsy specimens: a multi-institutional retrospective study.
Miyasaka Y; Yoshimoto Y; Murata K; Noda SE; Ando K; Ebara T; Okonogi N; Kaminuma T; Yamada S; Ikota H; Yokoo H; Ohno T; Nakano T
J Radiat Res; 2020 Mar; 61(2):275-284. PubMed ID: 32052042
[TBL] [Abstract][Full Text] [Related]
36. Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor.
Zhang W; Pang Q; Zhang X; Yan C; Wang Q; Yang J; Yu S; Liu X; Pan Y; Yuan Z; Wang P; Xiao Z
Cancer Sci; 2017 Apr; 108(4):590-597. PubMed ID: 28192623
[TBL] [Abstract][Full Text] [Related]
37. Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy.
Liang Y; Yu M; Zhou C; Zhu X
Diagn Pathol; 2020 Jun; 15(1):67. PubMed ID: 32493336
[TBL] [Abstract][Full Text] [Related]
38. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
39. Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway.
Guo Y; Shen R; Wang F; Wang Y; Xia P; Wu R; Liu X; Ye W; Tian Y; Wang D
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6315-6328. PubMed ID: 36745223
[TBL] [Abstract][Full Text] [Related]
40. Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
Okano N; Suefuji H; Nakajima M; Tokumaru S; Kubo N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
J Radiat Res; 2023 Jun; 64(Supplement_1):i2-i7. PubMed ID: 37036751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
